Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
March 21 2024 - 8:00AM
Psychemedics Corporation (NASDAQ: PMD), a global leader in drug
testing using hair analysis, is proud to announce its recognition
as one of the Top 10 Employee Health Testing Services Providers for
2024 by ManageHR. This prestigious accolade highlights
Psychemedics’ commitment to excellence and innovation in the field
of employee health testing.
ManageHR’s annual list recognizes companies that excel in
providing cutting-edge solutions and services for employee health
testing. Psychemedics was selected for its exceptional performance,
industry leadership, and dedication to delivering reliable and
accurate testing services.
“We are honored to be recognized as one of the Top 10 Employee
Health Testing Services Providers,” said Brian Hullinger, Chief
Executive Officer and President of Psychemedics Corporation. “This
achievement is a testament to our unwavering commitment to
providing high-quality, innovative solutions for drug testing.”
Psychemedics’ patented hair analysis technology offers a
non-invasive and highly accurate method for detecting drug use over
an extended period, providing employers with valuable insights into
their employees’ health and well-being. With over 30 years of
experience, Psychemedics has helped thousands of companies
worldwide maintain safe and drug-free workplaces.
For more information about Psychemedics Corporation and its
innovative hair testing solutions, please visit
https://www.psychemedics.com.
About Psychemedics
Psychemedics Corporation (NASDAQ: PMD) is a leading global
provider of innovative hair testing for drugs of abuse. With over
30 years of experience, Psychemedics has pioneered the science of
hair testing and provides clients with the most accurate and
reliable hair drug test results in the industry. The company's
patented technology is used by thousands of companies worldwide to
screen applicants and employees for drug use, helping to create
safer and more productive workplaces.
Investor Relations:Phone: 978-206-8220Email:
InvestorRelations@psychemedics.com
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
From May 2024 to Jun 2024
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
From Jun 2023 to Jun 2024